Cysteines β93 and β112 as Probes of Conformational and Functional Events at the Human Hemoglobin Subunit Interfaces  by Vásquez, Gregory B. et al.
Cysteines 93 and 112 as Probes of Conformational and Functional
Events at the Human Hemoglobin Subunit Interfaces
Gregory B. Va´squez,* Michael Karavitis,# Xinhua Ji,* Igor Pechik,* William S. Brinigar,§ Gary L. Gilliland,* and
Clara Fronticelli#
*Center for Advanced Research in Biotechnology of the University of Maryland Biotechnology Institute and National Institute of Standards
and Technology, Rockville, Maryland 20850, #Department of Biochemistry and Molecular Biology, University of Maryland Medical School,
Baltimore, Maryland 21201, and §Department of Chemistry, Temple University, Philadelphia, Pennsylvania 19122 USA
ABSTRACT Three variants of tetrameric human hemoglobin, with changes at the 12/21-interface, at the 11/22-
interface, and at both interfaces, have been constructed. At 12/21-interface the 93 cysteine was replaced by alanine
(C93A), and at the 11/22-interface the 112 cysteine was replaced by glycine (C112G). The 12 interface variant,
C93A, and the 11/12 double mutant, (C93AC112G), were crystallized in the T-state, and the structures determined
at 2.0 and 1.8 Å resolution, respectively. A comparison of the structures with that of natural hemoglobin A shows the absence
of detectable changes in the tertiary folding of the protein or in the T-state quaternary assembly. At the 112 site, the void
left by the removal of the cysteine side chain is filled by a water molecule, and the functional characteristics of C112G are
essentially those of human hemoglobin A. At the 93 site, water molecules do not replace the cysteine side chain, and the
alanine substitution increases the conformational freedom of 146His, weakening the important interaction of this residue
with 94Asp. As a result, when Cl is present in the solution, at a concentration 100 mM, the Bohr effect of the two mutants
carrying the 93Cys3Ala substitution, C93A and (C93AC112G), is significantly modified being practically absent below
pH 7.4. Based on the crystallographic data, we attribute these effects to the competition between 94Asp and Cl in the salt
link with 146His in T-state hemoglobin. These results point to an interplay between the His146-Asp94 salt bridge and the
Cl in solution regulated by the Cys present at position 93, indicating yet another role of 93 Cys in the regulation of
hemoglobin function.
INTRODUCTION
Human erythrocyte hemoglobin functions as an oxygen
carrier in the transport system that moves oxygen from the
lungs to the other tissues of the body. Each of the subunits
contains a heme group that is capable of binding oxygen or
other ligands. Binding of ligands is cooperative in that when
oxygen binds to one of the subunits, it facilitates the binding
of oxygen to the other subunits. Hemoglobin’s cooperativity
is associated with the allosteric transition from the T-state to
the R-state (T for tense and R for relaxed) (Perutz, 1989).
The allosteric nature of hemoglobin is the result of the
subunits packing in the tetramer that allows significant
quaternary changes to occur during ligand binding. The
tetramer assembles forming two different interfaces. The
11 (and 22) interface between the - and -subunits of
the dimer is quite stable with the relative positions of the
two subunits being unmodified by the state of ligation of the
protein. In contrast, two -dimers assemble forming the
12/21-interfaces that mediate the quaternary changes
associated with ligand binding (Ackers et al., 1992).
The -subunit has two cysteine residues, 93Cys and
112Cys, that are associated with the two hemoglobin in-
terfaces. At the 12/12-interface, a cysteine is present at
position 93; this residue is highly conserved in mammalian
hemoglobins. Recently, it has been proposed that 93Cys
plays a role in NO transport and delivery (Jia et al., 1996).
The cysteine at 112 forms part of the 11/22-interface
and is not highly conserved in mammalian hemoglobins.
Because these are the only cysteines present in the -chains,
their replacement by other residues can be used to probe
conformational and functional events occurring at the two
different interfaces upon ligand binding. Thus, three recom-
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binant hemoglobins were constructed by replacement of one
or both of the two cysteines.
The 112Cys was replaced by glycine in order to intro-
duce a void and thereby increase the flexibility of the
11/22 interface. The 93Cys was replaced by alanine;
this apolar substitution prevents H-bonding to 94Asp, ob-
served when 93Cys was replaced with the polar serine
(Luisi and Nagai, 1986), and the smaller side chain elimi-
nates the conformational effect associated to the different
exposition of the suphydryl group to the solvent observed in
R- and T-state hemoglobin. The two mutations were com-
bined in (C93AC112G) in order to assess whether the
combination of the two mutations would have additional
effects. C112G and (C93AC112G) were crystallized in
the deoxy form, and the structures determined at 2.0 and 1.8
Å resolution, respectively. The crystallographic analysis
indicates that neither the single nor double amino acid
replacement alters the tertiary folding of the protein or the
T-state quaternary assembly. At the 112 site, the void left
by the removal of the cysteine side chain is filled by a water
molecule, and the functional characteristics of C112G are
essentially those of human hemoglobin A (HbA). At the
93 site, the void left by the mutation does not appear to be
filled with a water molecule and the cysteine to alanine
substitution increases the conformational freedom of
146His, weakening the important interaction of this resi-
due with 94Asp.
Whereas the 112Cys3Gly mutation does not alter the
functional characteristics of hemoglobin, the Bohr effect of
the two mutants carrying the 93Cys3Ala substitution,
C93A and (C93AC112G), is modified when Cl are
present in the solution. Thermodynamic analysis suggests
that the 93Cys3Ala mutation hinders the contribution to
the Bohr effect of a group with a pKa lower than 7.6. Based
on the crystallographic data, we attribute this phenomenon
to the weakened interaction of 146His and 94Asp. Thus,
these data suggest that 93Cys plays a structural role in
controlling this important interaction, pointing to yet an-
other role of 93Cys in hemoglobin function.
MATERIALS AND METHODS
Protein expression and purification
Growth, expression, and purification of the fusion protein followed a
previously described protocol (Fronticelli et al., 1991). The extent of
enzymatic cleavage was monitored by reverse-phase high performance
liquid chromatography (Sanna et al., 1997). Reconstitution with the Cyano
heme and the -globin was as described (Fronticelli et al., 1991). The
hemoglobin was purified on an affinity column of immobilized hemoglo-
bin (Sanna et al., 1997.) The mutant hemoglobins were constructed as
previously described (Fronticelli et al., 1994). The purity of the recombi-
nant hemoglobin was established by Paragon gel electrophoresis (Beck-
man, Fullerton, CA), reverse-phase chromatography, and sequencing of the
first five amino acid residues. In all cases, the purity of the recombinant
hemoglobin was 95% or better.
Protein crystallization and x-ray data collection
and processing
The procedures for the crystallization of C112G and (C93AC112G)
hemoglobin variants and the x-ray data collection and processing are
similar to that described by Fronticelli et al. (1994b). The crystallization
procedure used was an adaptation of the procedure described by Perutz (1968).
The unit cell parameters for both crystals are given in Table 1. X-ray data
processing used the XENGEN program system (Howard et al., 1987). The
C112G (1GBV) crystal data included 50,688 total observations of 34,600
unique reflections. The redundancy of the data set is 1.46, and 92.8% of the
possible reflections were observed. The unweighted Rsym of the data set is
0.06, and the average I/(I) at 2.0 Å resolution is 2.3. The (C93AC112G)
(1GBU) diffraction data set is composed of 131,074 observations of 41,926
unique reflections. This includes 82.7% of the measurable reflections at 1.8 Å
resolution. The redundancy of the data is 3.1, the unweighted Rsym is 0.08, and
the I/(I) is 1.1 in the outermost resolution shell.
Crystal structure determination and refinement of
1GBV and 1GBU
The refinement of human, recombinant mutant hemoglobins C112G and
(C93AC112G) used a virtually identical protocol to that of the human
deoxyhemoglobin HbA (Fronticelli et al., 1994b), minimizing differences
between the structures resulting from variations in experimental and/or
refinement protocols. The starting model for the T-state C112G and
(C93AC112G) structures was the high-resolution deoxyhemoglobin A
structure, 2HHD (Fronticelli et al., 1994b). Initial refinement was carried
out using the X-PLOR 3.1 program package (Brunger, 1992). Rigid-body
refinement of the tetramer was followed by rigid-body refinement of the
individual subunits to correct the position of the molecule within the unit
cell. Using this procedure, the crystallographic R values [R  (Fo 
Fe)/Fo], summed over all hkl’s (reciprocal space coordinates) dropped
significantly. Next, simulated annealing was carried out with a slow
cooling protocol (Brunger et al., 1990). The force fields used were based
on the dictionary compiled by Engh and Huber (1991). Empirical energy
parameters for the water molecules were taken from TIP3p model of the
program CHARMM. The full charges of aspartate, glutamate, arginine, and
lysine were turned off during both dynamics and conventional minimiza-
tion. Before dynamics, the structures were minimized with 100 cycles of
TABLE 1 Crystallographic parameters and refinement
statistics for partially ligated 1GBV and deoxy-1GBU
Partially ligated
1GBV
Deoxy
1GBU
Space group P21 P21
Unit cell dimensions
a (Å) 63.2 63.0
b (Å) 83.6 82.9
c (Å) 53.7 53.8
(°) 99.6 99.2
Resolution (Å) 6.0–2.0 6.0–1.8
Rsym
1 0.06 0.08
Reflections (I  2 (I)) 34,600 41,926
Number of protein atoms 4556 4550
Number of solvent
molecules
367 454
R value 0.18 0.17
Deviations, rms:
Bond distances (Å) 0.02 0.02
Angle distances (Å) 0.04 0.04
1Rsym  G(Iij  GijIj)/GIij in which Gij  gi  Aisj  Bisj2; s  sin2/8;
g, A, and B are scaling parameters.
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conjugant gradient minimization to relieve bad contacts. The final crystal-
lographic R value after annealing was 0.24 for 1GBV and 0.22 for 1GBU.
Further refinement for both structures was carried out on a CRAY
Y-MP computer with GPRLSA (Furey et al., 1982), a restrained least-
squares refinement procedure (Hendrickson, 1985), with periodic adjust-
ments of the model using FRODO (Jones, 1978) or O (Jones et al., 1991).
Two types of electron density maps were used in the fitting, 2Fo  Fc and
Fo  Fc maps. Contour levels for the 2Fo  Fc and Fo  Fc map ranged
from 0.70 to 1.0  and 2.0 to 3.0 , respectively. Multiple rounds of
refinement, 30 for C112G and 20 for (C93AC112G), followed by
model adjustment were performed to eliminate difference peaks in the
Fo  Fc map above 3.0  and account for all of the 2Fo  Fc electron
density. A summary of the refinement statistics is presented in Table 1.
The coordinates and structure factors of the two hemoglobin variants
have been deposited in the Brookhaven Protein Data Bank with entry
identifiers 1GBV for -oxy--deoxy-(C112G) and 1GBU for deoxy-
(C93AC112G).
Oxygen equilibrium curves
Oxygen equilibrium measurements were performed using the thin layer
dilution technique of Dolman and Gill (1978) with an AVIV 14DS spec-
trophotometer. Formation of methemoglobin as judged by spectral decom-
position of the initial and final spectra was less than 10%, eliminating the
need for adding a reducing system. Protein concentration was between 1.5
and 2.0 mM in heme, a concentration at which dimers and their associated
complications are negligible. The buffer was 50 mM MES/HEPES/TAPS,
depending on the pH  100 mM Cl, temperature 25°C. The binding
isotherms were fitted to the Adair equation (1925),
Y
4

1p	O2
 22p	O2
2 33p	O2
3 44p	O2
4
1 1p	O2
 2p	O2
2 3p	O2
3 4p	O2
4
(1)
in which Y is the fractional saturation with O2, P(O)2 is the partial pressure
of oxygen in millimeters of mercury, and i are the overall Adair constants.
An iterative procedure incorporating the Marquardt algorithm was used,
and the value of the median ligand activity, Pm, was determinated by Pm 
4
0.25 (Wyman and Gill, 1990). The experimental points are well de-
scribed using the linkage equation
logPm logPmo log	1 K1 X
/	1 K2 X
 (2)
in which X represents the free protons concentration, and K1 and K2 are the
proton association constants of liganded (K2) and unliganded (K1) hemo-
globin. The derivative
H  log Pm/pH (3)
yields the total numer of protons exchanged with logPm/pH representing
the binding capacity of the Bohr groups for the protons (Di Cera et al.,
1988 ). Because of the inherent symmetry of Eq. 2, the maximum of the
binding capacity plot corresponds on the abscissa to the median ligand
activity, here indicated as pKm, of all the Bohr effect groups, and on the
ordinate to the maximum number of protons, Hmax, exchanged during
the R-T transition (Wyman and Gill, 1990). The area under the binding
capacity curve multiplied by 2.303RT gives the total free energy of Bohr
protons binding per mole of oxygen bound.
RESULTS
Structures of C112G and (C93AC112G).
The structure of the C112G mutant (1GBV) contains a
tetramer in the asymmetric unit that consists of complete -
and -globin polypeptides and their associated hemes along
with 367 water molecules (Table 1). Surprisingly, the
-subunits of this high-salt, T-state crystalline form of he-
moglobin have oxygen bound. The 1-subunit has full oc-
cupancy of the ligand, and the 2-subunit has partial occu-
pancy (0.7). The coordinates associated with the mutation
site are well determined. The region of the final 2Fo  Fc
electron density map in the vicinity of the mutation site is
shown in Fig. 1 a.
The final structure of deoxy (C93AC112G) (1GBU)
also contains a tetramer in the asymmetric unit and consists
of complete - and -globin polypeptides and their associ-
ated hemes along with 454 solvent molecules (Table 1). The
mutation sites at the two interfaces again are well deter-
mined. The temperature factors of the atoms of the substi-
tuted residues in both 1GBV and 1GBU are similar to those
of residues that are closely associated with the sites. The
final 2Fo  Fc electron density map in the vicinity of the
mutation sites is shown in Fig. 1 b and c.
The best C alignment of the mutant structures with natural
deoxy HbA, 2HHD (Fronticelli et al., 1994b), shows that both
deoxy C112G and (C93AC112G) have similar quater-
nary structures to that of 2HHD, with an RMSD of 0.35 and
0.31 Å, respectively, for the full tetramers (Table 2). 1GBV
and 1GBU were examined for diagnostic T- and R-state salt
bridges (Perutz, 1989) and compared with 2HHD and the fully
oxygenated R-state 1HHO structure (Shaanan, 1983) (Table
3). The distances measured for 1GBV are consistent with those
reported for the T-state structure. The 1GBU salt bridges are
also consistent with T-state structure, but there seems to be a
slight perturbation caused by the 93 mutation, as evidenced
by an absence of the T-state, salt bridge between 1Asp94 and
1His146. Closer examination of this area reveals that the
1His146 has rotated away from 1Asp94. The 1Lys40-
2His146 and 2Lys40-1His146 salt bridges in 1GBU are
also noticeably longer than those of 2HHD or 1GBV, but are
still present.
Influence of the Cys112Gly and Cys93Ala
mutations on the structure of the -subunits
The comparison of the -subunits of 1GBV, 1GBU, and
2HHD confirms that the variant chains are nearly identical
to that observed for natural hemoglobin (Figs. 2 and 3). The
comparison of the structures of 2HHD (Fronticelli et al.,
1994b) and both mutants in the 93 and 112 regions indicates
nearly identical backbone and side chain conformations, loca-
tion of solvent and sulfate, hydrogen bonds, and electrostatic
interactions. At the 112 site, the hole left by removal of the
-methylene and sulfhydryl when glycine replaced cysteine is
filled by a single water molecule in both -subunits in both
mutants. This water is bound to two other water molecules that
are associated with the -subunits of both mutant hemoglobins
and 2HHD (Figs. 1 and 2). The electron density of the 1GBU
93 sites clearly shows that cysteine has been replaced by
alanine, but no solvent fills the voids left by removal of the
sulfhydryl groups (Figs. 1 and 3).
Though there are no obvious perturbations at the 112
mutation sites, there is a subtle change in the area of the 93
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mutation sites. In the native deoxyhemoglobin structure,
2HHD, there is a salt bridge between 94 Asp and 146 His
at the C-terminal residue of the same chain. In 1GBU, there
is an inconsistency between the 1 and 2 subunits in which
the 2 chain maintains the Asp94-His146 salt bridge, but the
1 chain does not (Fig. 3). Even in the 2 salt bridge that is
maintained, the His146 side chain is oriented much differ-
ently than the side chains of 2HHD or 1GBV. This implies
that removal of the bulky Cys93 sulfhydryl group with the
change to Ala, permits His146 to sample more conforma-
tional space and adopt alternative side-chain conformations.
Functional characteristics
In natural HbA, protons bind preferentially to the deoxy-
genated form of hemoglobin above pH 6.0–6.5, and this is
referred to as the alkaline Bohr effect. Below pH 6.0- 6.5,
protons bind preferentially to the oxygenated form of he-
moglobin, and this is referred to as the acid Bohr effect. The
study of the pH dependence of oxygen affinity is thus a
sensitive tool for investigating structure-function relation-
ships in hemoglobin. The Bohr effect of C112G was
studied with oxygen equilibrium measurements, and the
FIGURE 1 Stereoplots of the coor-
dinates (a) of the 1C112G mutation
site for 1GBV, (b) of the 1C112G
mutation site for 1GBU, and (c) of
the 1C93A mutation site for 1GBU
superimposed on the 2Fo  Fc elec-
tron density map for each region con-
toured at 1 
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binding isotherms were analyzed according to Eq. 1. Fig. 4
shows the Bohr effect of HbA and C112G measured at
25°C in 50 mM MES/HEPES/TAPS  100 mM Cl. The
points represent the experimental data, and the interpolated
lines were drawn according to Eq. 2. Consistent with the
absence of structural modification, as indicated by the crys-
tallographic analysis, the Bohr effect of HbA and C112G
is essentially the same. In Fig. 5, the Bohr effect of
C112G, which is taken as the reference recombinant he-
moglobin, is compared with that of C93A and (C93A
C112G). Whereas the oxygen affinity and the alkaline Bohr
effect of the two mutants carrying the 93 Cys3Ala mu-
tation are indistinguishable, their functional characteristics
are modified with respect to C112G. The C112G,
C93A, and (C93AC112G) mutants have the same ox-
ygen affinity until pH 7.5, but in the 93 mutants, the
Bohr effect is modified, practically ending at pH 7.4. These
functional modification were, however, not observed when
the Bohr effect measurements were carried out in the ab-
sence of Cl. This is shown in Fig. 6 in which the Bohr
effect of HbA, C112G, and (C93AC112G) is practi-
cally indistinguishable.
The proton binding capacity of HbA and the mutant
hemoglobins was derived using Eq. 3. The related parame-
ters are listed in Table 4. In the absence of Cl, HbA and the
three mutant hemoglobins have identical binding capacities,
the pKm of the Bohr effect groups is 7.0, the maximum
number of proton released Hmax is 0.54/heme, and the
free energy of proton binding is 1.4 kcal/mol. In the pres-
ence of 100 mM Cl, HbA and C112G have the same
protons binding capacity; however, as indicated in Fig. 7,
differences are present between C112G and the
93Cys3Ala mutant hemoglobins. In the 93 mutants, the
pKm of the Bohr effect groups is shifted 0.4 units of pH
from 7.6 to 8.0, the maximum number of protons released is
decreased from 0.6.3 to 0.49/heme, the free energy of pro-
ton binding is decreased from 1.8 to 1.3 kcal/mol.
DISCUSSION
Influence of the 93 and 112 mutations on the
structure of C112G and (C93AC112G).
Perhaps not surprisingly, only small perturbations in the
structure are observed in the comparison of the T-state
structures of the variant hemoglobinsC112Gand(C93A
C112G) with natural T-state deoxyhemoglobin, 2HHD.
Also, there is no obvious correlation between the structure
and the ligation state of the single site mutant, C112G, and
that of the double site mutant, (C93AC112G). This is
not too surprising as there is little change in the  dimer
interface with ligand binding. The waters that fill the void
left by the removal of the Cys112 side chain in its replace-
ment by Gly appear to compensate for the lost van der
Waals area and preserve the integrity of the structure in
those areas of both mutant structures, 1GBV and 1GBU. The
mutation at the 93 site is more complicated because the
Cys3Ala substitution seems to influence the conformation of
the C-terminal His146. The cavity left by the mutation is not
large enough to accommodate a water molecule that could
maintain a van der Waals contact with His146. The 1GBU
His146 is then able to sample more conformational space,
which may enable more dynamic movement in the T-state, and
that may in turn account for the loss of the salt bridge in the 1
subunit and the altered positioning in the 2 subunit.
Functional characteristics
Differential gel filtration measurements indicated that the
mutation 93Cys3Ala or 112Cys3Gly does not modify
the dimer-tetramer association constants (Fronticelli et al.,
1994a). Thus, also in solution these recombinant hemoglo-
bins have the tetrameric assembly of natural HbA. The
absence of conformational modifications in C112G is re-
flected in its functionality, which is similar to that of natural
HbA (Fig. 4, Table 4). The replacement of the cysteine side
chains with a water molecule probably prevents the mani-
TABLE 2 Tertiary and quaternary comparisons by RMS
deviations of Ca alignments of 1GBV, 1GBU, and
deoxyhemoglobin A, 2HHD
2HHD versus
1GBV versus
1GBU (Å)1GBV (Å) 1GBU (Å)
1 0.27 0.25 0.21
1 0.24 0.24 0.19
2 0.24 0.24 0.19
2 0.30 0.28 0.25
11 0.28 0.27 0.20
22 0.29 0.29 0.21
1212 0.35 0.31 0.22
TABLE 3 Comparison of diagnostic T- and R-state salt
bridge distances of 1GBV and 1GBU to deoxyhemoglobin A,
2HHD, and the fully oxygenated 1HHO structure
Salt Bridge
Distances (Å)
Diagnostic
state (T/R)2HHD 1GBU 1GBV 1HHO
R/T State T T T R
1V1-1S131 4.6 5.4 6.3 4.9 T
2V1-2S131 5.9 6.0 5.8 4.9 T
1K127-2R141 2.9 2.9 2.8 20.9 T
1D126-2R141 2.8 2.6 2.5 12.4 T
2K127-1R141 3.2 2.7 3.1 20.9 T
2D126-1R141 2.7 2.6 2.6 12.4 T
1Y42-2D99 2.7 2.6 2.5 9.4 T
1D94-2N102 5.9 5.7 5.7 2.9 R
2Y42-1D99 2.7 2.6 2.4 9.4 T
2D94-1N102 5.5 5.8 5.6 2.9 R
1K40-2H146 2.7 3.2 2.9 31.4 T
2D94-2H146 2.7 2.4 2.7 11.0 T
2K144-2H146 12.0 12.5 12.3 3.1 R
2K40-1H146 2.5 3.1 2.4 31.4 T
1D94-1H146 2.8 3.8 3.1 11.0 T
1K144-1H146 12.4 11.7 11.7 3.1 R
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festation of conformational changes by filling the void left
by the removal of the cysteine side chain. Because of the
conformational and functional similarities with natural
HbA, C112G is taken as reference recombinant hemoglo-
bin for evaluating the functional effects of the single
93Cys3Ala and of the double 93 Cys3Ala 
112Cys3Gly amino acid substitutions.
The functional characteristics of C93A and
(C93AC112G) are indistinguishable, consistent with the
absence of conformational or functional modifications caused
by the 112Cys3Gly substitution. In the presence of 100 mM
Cl, the replacement 93 Cys3Ala at the 12 interface affects
the functional properties of hemoglobin and the alkaline Bohr
effect practically ends at pH 7.4 (Fig. 5). As a result, the
FIGURE 2 Plots of the comparison of the (a) 1C112G and (b) the 2C112G mutation sites in 1GBU (magenta), 1GBV (green) with natural
deoxyhemoglobin, and 2HHD (Fronticelli et al., 1994a) (colored by atom type). The conserved water molecules are labeled W1 and W2, and water
molecules that replace the cysteine side chain are labeled Wm.
Va´squez et al. Hemoglobin Subunit Interface Probes 93
protons binding capacity of the 93 mutants, is modified. The
maximum of the curve and thus the pKm of the Bohr groups
activity is shifted by 0.4 units of pH, from 7.6 to 8.0. The
maximum number of protons released upon oxygenation is
decreased about 22% from 0.63/heme to 0.49/heme. The free
energy of Bohr proton binding is decreased 0.5 kcal/heme from
1.8 to 1.3 kcal/heme. We attribute the origin of this functional
effect to the increased conformational freedom of 146His.
Crystallographic analysis indicates that upon the
93Cys3Ala substitution the distance between 146His-
COO and 40Lys is increased from 2.8 to 3.1 Å, weakening
this salt bridge (Table 3), and that 146His assumes positions
that do not allow the formation of the salt bridge with 94Asp
(Fig. 3 and Table 3). This is functionally very relevant as
146His is believed to contribute to the alkaline Bohr effect
when by interacting with 94Asp in T-state hemoglobin,
FIGURE 3 Plots of the comparison of (a) the 1C93A and (b) the 2C93A mutation sites in 1GBU (magenta) with 1GBV (green) and natural
deoxyhemoglobin, 2HHD (colored by atom type).
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forms a strong ionic interaction that increases its pKa (Perutz et
al., 1980). The decreased binding capacity and the shift in the
pH of maximum proton release from 7.6 to 8.0 observed for
the 93 mutants in the presence of Cl (Fig. 7, Table 4)
suggests the decreased contribution of a Bohr effect group with
a pKa somewhat lower than 7.6. This is consistent with the pKa
of 7.0 and 8.0 calculated by NMR measurements for 146His
in oxy and deoxy hemoglobin, respectively (Kilmartin et al.,
1973). In contrast, when Cl are absent from the solvent, the
93Cys3Ala mutants have the same binding capacity and
Bohr effect of C112G and of HbA. (Fig. 6, Table 4). It is
reasonable to propose that in C93A and (C93AC112G)
in which in T-state 146His is more mobile, the Cl in the
solution shields the positive charge of 146His, hindering its
interaction with 94Asp and thus altering its contribution to
the Bohr effect. The possibility of an interplay between
146His-94Asp salt bridge and the Cl in the solution is
supported by 35Cl NMR measurements indicating binding of
Cl at 146His in deoxy HbA (Chiancone et al., 1975), and by
the low energy value of the 146His-94Asp salt bridge (1
kcal/mol) (Louie et al., 1988), which suggests the presence of
competing interactions. In this regard we want to stress that the
modification of the free energy of proton binding measured for
the 93 mutants is of 0.5 kcal/heme or 2.0 kcal/tetramer (Table
4). This value matches the free energy of 2.0 kcal/tetramer
required for the formation of two 146His-94Asp salt
bridges, supporting the proposal that the modified 146His-
FIGURE 4 An overlay of the Bohr effect of HbA (E) and C112G ().
The symbols represent the experimental data points. Solid lines are drawn
using a nonlinear least squares analysis (Eq. 2 in the text). The oxygen
equilibrium measurements were done in 50 mM MES/HEPES/TAPS 
100 mM Cl at 25°C.
FIGURE 5 An overlay of the Bohr effect of C112G (), C93A (‚),
and (C93AC112G) (). The symbols represent the experimental data
points. Solid lines are drawn using a nonlinear least squares analysis (Eq.
2 in the text). The oxygen equilibrium measurements were done in 50 mM
MES/HEPES/TAPS  100 mM Cl at 25°C.
FIGURE 6 An overlay of the Bohr effect in the absence of NaCl for
HbA (E), C112G (), and (C93AC112G) (). The symbols repre-
sent the experimental data points. Solid lines are drawn using a nonlinear
least squares analysis (Eq. 2 in the text). The oxygen equilibrium mea-
surements were done in 50 mM MES/HEPES/TAPS at 25°C.
TABLE 4 Thermodynamic parameters in the absence and in
the presence of 100 mM Cl, derived for HbA, C112G,
C93A, and (C93AC112G)
Protein
NaCl
(mM) Hmax
 /heme pKm
G
(kcal/heme)
HbA 0 0.54 7.0 1.4
C112G 0 0.54 7.0 1.4
C93A (C93AC112G) 0 0.54 7.0 1.4
HbA 100 0.62 7.5 1.7
C112G 100 0.63 7.6 1.8
C93A (C93AC112G) 100 0.49 8.0 1.3
Measurements were done in 50 mM MOPS/HEPES/TAPS buffer at 25°C.
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94Asp interaction seen by x-ray crystallography is responsi-
ble for the observed effect.
All of the recombinant hemoglobins have a decreased
cooperativity, this is especially evident when Cl are absent
from the solvent. This has also been observed with recom-
binant hemoglobins obtained with other expression systems
(Nagai et al., 1985; Hernan and Sligar, 1995) but not for
Escherichia coli expressed, soluble recombinant hemoglo-
bins that have been through an oxi-reduction cycle (Shen et
al., 1993), or for soluble hemoglobin expressed in yeast (De
Llano et al., 1993). NMR measurements indicated the cor-
rect tetrameric assembly of our recombinant hemoglobins.
We attributed the decreased cooperativity to phenomena
occurring at the intermediates of oxygenation, (Sanna et al.,
1997). The oxygen equilibrium curves obtained in the ab-
sence of Cl suggest that this effect is enhanced in the
absence of effectors.
93Cys as a Bohr effect group
As the Bohr effect is decreased upon the removal of the
Cys93 sulfhydryl group, the possibility that 93Cys could
itself be an alkaline Bohr effect group should be addressed.
A possible role of cysteine in the regulation of the Bohr
effect was proposed by Riggs (1960) and is consistent with
the different conformations of 93Cys in the T- and R-state
structures. Biochemical studies show that 93Cys can be
alkylated only while in the R-state (Riggs, 1961), which
may be explained by an R-state thiolate group, though
sulfhydryls are nucleophilic enough to interact with alky-
lating agents without the formation of a thiolate. Examina-
tion of the conformations and interactions of 93Cys in the
HbA structures solved in our laboratory, deoxy HbA
(2HHD) (Fronticelli et al., 1994b) and carboxy HbA (1AJ9)
(Va´squez et al., 1998), show that in both allosteric confor-
mations, the temperature factors of 93Cys sulfhydryl
groups were 10 and 28 Å2, respectively, indicating that
there was not unusual thermal motion of the side chains,
thereby providing confidence in the assignment their posi-
tions. In the T-state structures, 93Cys is accessible to the
solvent but does not establish interactions with other polar
residues in the protein, in particular, basic residues, which
are at a distances of at least 8 Å away, respectively. In all
the current R-state structures, carboxyhemoglobins 1AJ9
(Vasquez et al., 1998) and 2HCO (Baldwin, 1980), oxyhe-
moglobin, 1HHO (Shaanan, 1983), and R2 structure 1BBB
(Silva et al., 1992), 93Cys is less accessible to the solvent
and at 6.7, 7.0, 6.5, and 6.84 Å distance, respectively, from
the closest basic residue, the proximal histidine. This dis-
tance is too large for establishing interaction capable to
stabilize a thiolate form of the sulfhydryl. Thus, it is un-
likely that the b93Cys is an intrinsic alkaline Bohr effect
group.
There is the possibility that residues near 93Cys may be
potential alkaline Bohr effect groups through the influence
of Cys93, but after examination of the available structures,
only the penultimate 145Tyr was identified as a candidate.
The potential interaction of 93Cys would be through an
on-face H-bond from the sulfhydryl proton to the aromatic,
	 electron cloud of Tyr145. The distance between the
sulfhydryl sulfur and the tryrosine ring is 3.8 Å in the
R-state (1AJ9) and 4.3 Å in the T-state (2HHD), favoring
this interaction in the R-state, but making the interaction
improbable nonetheless. The 145Tyr is also an unlikely
alkaline Bohr effect group, because in a similar interaction
between a threonine hydroxyl group and a tyrosine in glu-
FIGURE 7 Bohr protons binding
capacity of C112G (), (C93A
C112G) () in the presence of 100
mM Cl. These curves were drawn
using Eq. 3.
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tathione S-transferase, the interaction only lowered the pKa
0.7 units (Liu et al., 1993) and the pKa of tyrosines range
from about 9.5 to 10.9 (Metzler, 1977).
This study points to a role of 93Cys in the modulation
of oxygen affinity. In fact, it is the substitution
93Cys3Ala that triggers the conformational changes and
the modification in the alkaline Bohr effect described in the
presence of Cl. It also suggests that the interaction of
146His with 94Asp is sensitive to the presence of Cl in
the solution.
We thank Dr. Walter Kisiel for the gift of Factor X and Dr. Enrico Bucci
for a critical reading of the manuscript. The technical help of Wenxian Nie
for the recombinant hemoglobin preparations is gratefully acknowledged.
This work was supported in part by the PHS National Institutes of Health
Grant PO1-HL-48517.
REFERENCES
Ackers, G. K., M. L. Doyle, D. Myers, and M. A. Daugherty. 1992.
Molecular code for cooperativity in hemoglobin. Science. 255:54–63.
Adair GS. 1925. J. Biol. Chem. 63:529–545.
Baldwin, J. M. 1980. The structure of human carbonmonoxy haemoglobin
at 2.7 A resolution. J. Mol. Biol. 136:103–128.
Bernstein, F. C., T. F. Koetzle, G. J. B. Williams, E. F. Meyer Jr., M. D.
Brice, J. R. Rogers, O. Kennard, T. Shimanouchi, and M. Tasumi. 1977.
The protein data bank: a computer-based archival file for macromolec-
ular structures. J. Mol. Biol. 112:535–547.
Brunger, A. T. 1992. X-PLOR, Version 3.1 Yale University Press, New
Haven.
Bru¨nger, A. T., A. Krukowski, and J. Erickson. 1990. Slow-cooling pro-
tocols for crystallographic refinement by simulated annealing. Acta
Crytallog. A46:585–593.
Chiancone, E, J. E. Norne, S. Forsen, J. Bonaventura, M. Brunori, E.
Antonini, and J. Wyman. 1975. Identification of chloride-binding sites in
hemoglobin by nuclear-magnetic-resonance quadrupole-relaxation stud-
ies of hemoglobin digests. Eur. J. Biochem. 5:385–390.
De Llano, J. J., O. Schneewind, G. Stetler, and J. M. Manning. 1993.
Recombinant human sickle hemoglobin expressed in yeast. Proc. Natl.
Acad. Sci. USA. 90:918–922
Di Cera, E., S. J. Gill, and J. Wyman. 1988. Binding capacity: cooperativity
and buffering in biopolymers. Proc. Natl. Acad. Sci. USA. 85:449–452
Dolman, D., and S. J. Gill. 1978. Membrane-covered thin-layer optical cell
for gas-reaction studies of hemoglobin. Anal. Biochem. 87:127–134.
Engh, R. A., and R. Huber. 1991. Accurate bond and angle parameters for
X-ray protein structure refinement. Acta Cryst. A47:392–400.
Fronticelli, C., M. Gattoni, A.-L. Lu, S. W. Brinigar, J. L. Bucci, and E.
Chiancone. 1994a. The dimer-tetramer equilibrium of recombinant he-
moglobins. Biophys. Chem. 51:53–57.
Fronticelli, C., J. K. O’Donnell, and W. S. Brinigar. 1991. Recombinant
human hemoglobin: expression and refolding of beta-globin from Esch-
erichia coli. J. Prot. Chem. 10:495–501.
Fronticelli, C., I. Pechik, W. S. Brinigar, L. Kowalczyk, and G. L. Gilli-
land. 1994b. Chloride ion independence of the Bohr effect in a mutant
human hemoglobin beta (V1MH2deleted). J. Biol. Chem. 269:
23965–23969.
Furey, W., B. C. Wang, and M. Sax. 1982. Crystallographic computing on
an array processor. J. Appl. Crystallogr. 15:160–166.
Hendrickson, W. 1985. Crystallographic Computing: Data Collection,
Structure Determination, Proteins, and Databases. G. Sheldrick, C.
Kruger, and R. Godard, editors. Clarendon Press, Oxford, UK. 306–311.
Hendrickson, W., and J. Konnert. 1980. Computing in Crystallography. R.
Diamond, S. Ramaseshan, and K. Venkatesan, editors. Indian Academy
of Sciences, Bangalore, India. 1301–1323.
Hernan, R. A., and S. G. Sligar. 1995. Tetrameric hemoglobin expressed in
Escherichia coli. J. Biol. Chem. 270:26257–26264.
Howard, A. J., G. L. Gilliland, B. C. Finzel, T. L. Poulos, D. H. Ohlendorf,
and F. R. Salemme. 1987. The use of an imaging proportional counter in
macromolecular crystallography. J. Appl. Crystallogr. 20:383–387.
Jia, L., C. Bonaventura, J. Bonaventura, and J. S. Stamler. 1996. S-
nitrosohaemoglobin: a dynamic activity of blood involved in vascular
control. Nature. 380:221–226.
Jones, T. A. 1978. A graphics model building and refinement system for
macromolecules. J. Appl. Crystallog. 11:268–272.
Jones, T. A., J.-Y. Zou, S. W. Cowan, and M. Kjeldgaard. 1991. Improved
methods for building protein models in electron density maps and the
location of errors in these models. J. Appl. Crystallogr. 11:268–272.
Kilmartin, J. V., J. J. Breen, J. C. K. Roberts, and C. Ho. 1973. Direct
measurement of the pK values of an alkaline Bohr group in human
hemoglobin. Proc. Natl. Acad. Sci. USA. 70:1246–1249.
Kilmartin, J. V., J. H. Fogg, and M. F. Perutz. 1980. Role of C-terminal
histidine in the alkaline Bohr effect of human hemoglobin. Biochemistry.
19:3189–3193.
Liu, S., X. Ji, G. L. Gilliland, W. J. Stevens, and R. N. Armstrong. 1993.
Second-sphere electrostatic effects in the active site of glutathione
S-transferase: observation of an on-face hydrogen bond between the side
chain of threonine 13 and the 	-cloud of tyrosine 6 and its influence on
catalysis. J. Am. Chem. Soc. 115:7910–7911.
Louie, G., T. Thao, J. J. Englander, and S. W. Englander. 1988. Allosteric
energy at the hemoglobin beta chain C terminous studied by hydrogen
exchange J. Mol. Biol. 201:755–764.
Luisi, B. F, and K. Nagai. 1986. Crystallographic analysis of mutant human
haemoglobins made in Escherichia coli. Nature. 320:552–556.
Metzler, D. E. 1977. Biochemistry: The Chemical Reactions of Living
Cells, Academic Press, New York.
Nagai, K., M. F. Perutz, and C. Poyart. 1985. Oxygen binding properties of
human mutant hemoglobins synthesized in E. coli. Proc. Natl. Acad. Sci.
USA. 82:7252–7255.
Perutz, M. F. 1968. Preparation of haemoglobin Crystals. J. Crystal
Growth. 2:54–56.
Perutz, M. F. 1989. Mechanisms of cooperativity and allosteric regulation
in proteins. Q. Rev. Biophys. 22:139–236.
Perutz, M. F., J. V. Kilmartin, K. Nishikura, J. H. Fogg, P. J. G. Butler, and
H. S. Rollema. 1980. Identification of residues contributing to the Bohr
effect of human haemoglobin. J. Mol. Biol. 138:649–668.
Riggs, A. 1960. The nature and significance of the Bohr effect in mam-
malian hemoglobins. J. General Physiol. 39:585–605.
Riggs, A. 1961. The binding of N-ethylmalemeide by human hemoglobin
and its effect upon the oxygen equilibrium. J. Biol. Chem. 236:
1948–1954.
Sanna, M. T., A. Razynska, M. Karavitis, A. P. Koley, F. K. Friedman,
I. M. Russu, W. S. Brinigar, and C. Fronticelli. 1997. Assembly of
human hemoglobin J. Biol. Chem. 272:3478–3486.
Shaanan, B. 1983. Structure of human oxyhaemoglobin at 2.1 A resolution.
J. Mol. Biol. 171:31–59.
Shen, T., N. T. Ho, V. Simplaceneau, M. Zou, B. N. Green, M. F. Tam, and
C. Ho. 1993. Production of unmodified human adult hemoglobin in E.
coli. Proc. Natl. Acad. Sci. USA. 90:8108–8112.
Silva, M. M., P. H. Rogers, and A. Arnone. 1992. A third quaternary
structure of human hemoglobin A at 1.7-A resolution. J. Biol. Chem.
267:17248–17256.
Va´squez, G. B., X. Ji, C. Fronticelli, and G. L. Gilliland. 1998. Human
carboxyhemoglobin at 2.2 Å resolution: structure and solvent compari-
sons of R-state, R2-state, and T-state hemoglobins. Acta Crystallo-
graphica. D54:355–366.
Wyman, J., and S. J. Gill. 1990. Binding and Linkage. University Science
Books, Mill Valley, CA.
Va´squez et al. Hemoglobin Subunit Interface Probes 97
